# MilliporeSigma awarded $136.7M US government contract for lateral flow membrane facility

MilliporeSigma, the US life science business of Merck KGaA, was awarded a $136.7 million contract from the US Department of Defense to construct a lateral flow membrane production facility in Sheboygan, Wisconsin, over three years.

- Type: Contract
- Announced: 2021-12-29
- Where: Sheboygan, Wisconsin, United States
- Value: $136.7M
- Status: announced
- Capacity: 85 million tests per month
- Products: Hi-Flow Plus lateral flow membrane
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [MilliporeSigma](https://endata.com/companies/7341.md)
- [Merck KGaA](https://endata.com/companies/1393.md) (investor)
- [Merck KGaA](https://endata.com/companies/1393.md) (partner)
- [U.S. Department of Defense](https://endata.com/companies/4836.md) (customer)
- [MilliporeSigma](https://endata.com/companies/7341.md) (supplier)

## Sources

- [biospace.com](https://www.biospace.com/milliporesigma-announces-136-7-million-u-s-government-contract-award-for-new-lateral-flow-membrane-production-facility-in-sheboygan-wisconsin), 2021-12-29: "With this agreement, MilliporeSigma will construct a state-of-the-art lateral flow membrane production facility that will give our in vitro diagnostic (IVD) manufacturing customers greater flexibility and security of supply of our Hi-Flow Plus lateral flow membranes."
- [apnews.com](https://apnews.com/press-release/pr-newswire/coronavirus-pandemic-technology-science-health-business-7eee137137abe831c2ca2c3f98bc5f9d), 2021-12-29: "MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, was awarded a $136.7M USD contract award for the construction of a lateral flow membrane production facility over a three-year period at the company’s Sheboygan, Wisconsin site."
- [foxbusiness.com](https://www.foxbusiness.com/politics/biden-inks-137m-deal-for-covid-test-strip-factory-to-be-built-over-3-years), 2021-12-30: "The Biden administration has signed a $137 million contract with a pharmaceutical company for the purpose of building a factory for COVID-19 test strip materials."
- [thehill.com](https://thehill.com/policy/healthcare/587676-pentagon-awards-1367m-contract-for-domestic-production-of-material-critical/), 2021-12-30: "This industrial base expansion effort will allow MilliporeSigma to establish a nitrocellulose manufacturing capability in its Sheboygan, Wisconsin facility to support more than 83.3 million tests per month for COVID-19 testing and future needs."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.